You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -1,326.0% | -1,233.3% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -9.8 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 111.8 | 159.8 |
| Price / Book value | 3.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 27.7% | -82.5% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -33.3% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-04-30 | 0.36 | -5.43 | -8.69p | -7.8 | 0.0 | n/a | n/a | 0.0% |
| 2017-04-30 | 0.50 | -7.41 | -8.95p | -5.8 | 0.0 | n/a | n/a | 0.0% |
| 2018-04-30 | 0.63 | -8.93 | -7.91p | -6.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-04-30 | 0.68 | -10.87 | -6.56p | -11.6 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 0.58 | -7.73 | -5.69p | -11.0 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 0.60 | -7.36 | -3.58p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-12-31 | 0.00 | 0.00 | 0.00p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Angle's Parsortix displays potential use for detection of immunotherapy efficacy Sharecast News | 14 Aug |
|---|---|
| Angle's 'Parsortix' advantageous in breast cancer in new research Sharecast News | 20 Jul |
| Angle upbeat on recent research using 'Parsortix' Sharecast News | 12 May |
| Holding(s) in Company | 11-Sep-20 15:36 |
|---|---|
| Holding(s) in Company | 11-Sep-20 15:31 |
| Notification of Interim Results and Webcast | 02-Sep-20 13:49 |
| Holding(s) in Company | 02-Sep-20 10:02 |
| Result of 2020 Annual General Meeting | 27-Aug-20 15:15 |